This Rambus Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Emera Incorporated
Micron Technology, Inc.
Nucor Corporation
Rambus Inc.
First Tracks Biotherapeutics Inc
Emera Incorporated EMA | 0.00 | |
Micron Technology, Inc. MU | 0.00 | |
Nucor Corporation NUE | 0.00 | |
Rambus Inc. RMBS | 0.00 | |
First Tracks Biotherapeutics Inc TRAX | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Tristan Gerra downgraded Rambus Inc (NASDAQ:RMBS) from Outperform to Neutral and maintained the price target of $120. Rambus shares closed at $141.31 on Monday. See how other analysts view this stock.
- UBS analyst Andrew Jones downgraded Nucor Corp (NYSE:NUE) from Buy to Neutral and raised the price target from $190 to $224. Nucor shares closed at $215.00 on Monday. See how other analysts view this stock.
- Scotiabank analyst Phil Hardie downgraded goeasy (TSX:GSY) from Sector Outperform to Sector Perform and lowered the price target from C$55 to C$39. See how other analysts view this stock.
- Scotiabank analyst Phil Hardie downgraded Propel Holdings (TSX:PRL) from Sector Outperform to Sector Perform and lowered the price target from C$35 to C$27. See how other analysts view this stock.
Considering buying RMBS stock? Here’s what analysts think:
Photo via Shutterstock